Our study showed a trend toward a reduction in body water, but body fat mass did not change; these findings were different from those of the past study.
← all excerpts
The sodium-glucose cotransporter 2 inhibitor ipragliflozin improves liver function and insulin resistance in Japanese patients with type 2 diabetes.
1
—
—